Restricted accessResearch articleFirst published online 2022-08
Whole Genome Sequencing of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolated from Neonatal Bloodstream Infections at a Neonatal Care Unit,Algeria
Neonatal bloodstream infections (BSIs) are an important cause of mortality among neonates. Besides, extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-Kp) is one of the most frequent pathogens causing neonatal BSIs. This study aimed to characterize ESBL-Kp strains recovered from neonatal BSI and to investigate risk factors associated with ESBL-Kp BSI at the neonatal care unit of Elmeki Hospital, Bejaia, Algeria.
Methodology:
After isolation, identification, and antibiotic susceptibility testing, the ESBL-Kp strains were characterized by whole genome sequencing. The genomes were then analyzed using bioinformatic tools to determine the resistome, virulome, and phylogenetic relatedness.
Results:
From September 2019 to May 2020, 27 (8.2%) out of 328 neonates were infected by ESBL-Kp strains. These strains displayed a multidrug-resistant phenotype, and on further investigation, were found to carry an array of antibiotic resistance genes. All ESBL-Kp strains harbored the blaCTX-M-15 gene. Using in silico multilocus sequence typing analysis, six sequence types (STs) were detected with ST268 being the most frequent (56%, n = 15) indicating a local outbreak, confirmed by single nucleotide polymorphism analysis. The yersiniabactin and colibactin gene clusters were identified in six and two ESBL-Kp strains, respectively.
Conclusion:
This study showed a high prevalence of CTX-M-15-producing K. pneumoniae strains coharboring different antibiotic resistance mechanisms from neonatal BSIs in Algeria. Screening of health care personnel and mothers for ESBL carriage before delivery, isolation of carriers, barrier precautions, antimicrobial usage, and control of hygiene are needed to prevent the dissemination of these pathogens.
Get full access to this article
View all access options for this article.
References
1.
SorsaA.2019. Epidemiology of neonatal sepsis and associated factors implicated: observational study at neonatal intensive care unit of Arsi University teaching and referral hospital, South East Ethiopia. Ethiop. J. Health Sci. 29:333–342.
2.
Zea-VeraA., and OchoaT.J.. 2015. Challenges in the diagnosis and management of neonatal sepsis. J. Trop. Pediatr. 61:1–13.
3.
AtifM.L., SadaouiF., BezzaouchaA., et al.2008. Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit. Infect. Control Hosp. Epidemiol. 29:1066–1070.
4.
CorbellaM., CaltagironeM., GaiarsaS., et al.2018. Characterization of an outbreak of extended-spectrum β-lactamase-producing klebsiella pneumoniae in a neonatal intensive care unit in Italy. Microb. Drug Resist. 24:1128–1136.
5.
GuptaA.2002. Hospital-acquired infections in the neonatal intensive care unit—Klebsiella pneumoniae. Semin. Perinatol. 26:340–345.
6.
CanteyJ.B., and MilstoneA.M. 2015. Bloodstream infections: epidemiology and resistance. Clin. Perinatol. 42:1–16, vii.
7.
LengletA., FaniyanO., and HopmanJ.. 2018. A nosocomial outbreak of clinical sepsis in a neonatal care unit (NCU) in Port-Au-Prince Haiti, July 2014- September 2015. PLoS. Curr. 10:ecurrents.outbreaks.58723332ec0de952adefd9a9b6905932.
8.
SinghN., PatelK.M, LégerM.-M, et al.2002. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr. Infect. Dis. J. 21:1029–1033.
9.
Ruppé, É., WoertherP.-L, and BarbierF.. 2015. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann. Intensive Care. 5:21.
10.
FolgoriL., and BielickiJ.. 2019. Future challenges in pediatric and neonatal sepsis: emerging pathogens and antimicrobial resistance. J. Pediatr. Intensive Care. 8:17–24.
11.
JolleyK.A., BrayJ.E, and MaidenM.C.J. 2018. Open-access bacterial population genomics: BIGSdb software, the. PubMLST.org website and their applications. Wellcome Open Res. 3:124.
12.
BertelsF., SilanderO.K, PachkovM., RaineyP.B, and van NimwegenE.. 2014. Automated reconstruction of whole-genome phylogenies from short-sequence reads. Mol. Biol. Evol. 31:1077–1088.
13.
NguyenL.-T., SchmidtH.A, von HaeselerA., and MinhB.Q.. 2015. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32:268–274.
14.
ZankariE., HasmanH., CosentinoS., et al.2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67:2640–2644.
15.
LiuB., ZhengD., JinQ., ChenL., and YangJ.. 2019. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 47:D687–D692.
16.
JohnsonJ., and QuachC.. 2017. Outbreaks in the neonatal ICU: a review of the literature. Curr. Opin. Infect Dis. 30:395–403.
17.
CrivaroV., BagattiniM., SalzaM.F, et al.2007. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J. Hosp. Infect. 67:135–141.
18.
ShakilS., AliS.Z, AkramM., AliS.M, and KhanA.U.. 2010. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J. Trop. Pediatr. 56:90–96.
19.
Lona-ReyesJ.C., Pérez-RamírezR.O, Rodríguez-PatiñoV., Cordero-ZamoraA., Gómez-RuizL.M, and Llamas-RamosL.. 2019. [Prevalence of extended-spectrum beta-lactamases in enterobacteria of neonatal sepsis and associated factors]. Rev. Chilena. Infectol. 36:433–441.
20.
CassettariV.C., da SilveiraI.R, DropaM., et al.2009. Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J. Hosp. Infect. 71:340–347.
21.
KimY.A., ParkY.S, KimB., SeoY.H, and LeeK.. 2020. Prevalence and risk factors for extended-spectrum β-lactamase-producing Klebsiella pneumoniae colonization in intensive care units. Ann. Lab. Med. 40:164–168.
22.
GhafourianS., SadeghifardN., SoheiliS., and SekawiZ.. 2015. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr. Issues. Mol. Biol. 17:11–21.
23.
AhmedZ.B., AyadA., MesliE., MessaiY., BakourR., and DrissiM.. 2012. CTX-M-15 extended-spectrum beta-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital, Algeria. East. Mediterr. Health. J. 18:382–386.
24.
BelbelZ., ChettibiH., DekhilM., LadjamaA., NedjaiS., and RolainJ.-M.. 2014. Outbreak of an armA methyltransferase-producing ST39 Klebsiella pneumoniae clone in a pediatric Algerian Hospital. Microb. Drug. Resist, 20:310–315.
25.
IabadeneH., MessaiY., AmmariH., et al.2009. Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals. Int. J. Antimicrob. Agents. 34:340–342.
26.
MessaiY., IabadeneH., BenhassineT., et al.2008. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol. Biol. (Paris). 56:319–325.
27.
Ramdani-BouguessaN., ManageiroV., Jones-DiasD., FerreiraE., TazirM., and CaniçaM.. 2011. Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital. J. Med. Microbiol. 60:983–987.
28.
TouatiA., TalbiM., MairiA., et al. 2020. Fecal carriage of extended-spectrum β-lactamase and carbapenemase-producing enterobacterales strains in patients with colorectal cancer in the oncology unit of Amizour Hospital, Algeria: a prospective cohort study. Microb. Drug Resist. 26:1383–1389.
29.
BachiriT., BakourS., LadjouziR., ThongpanL., RolainJ.M, and TouatiA.. 2017. High rates of CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in wild boars and Barbary macaques in Algeria. J. Glob. Antimicrob Resist. 8:35–40.
30.
BrahmiS., TouatiA., Dunyach-RemyC., SottoA., PantelA., and LavigneJ.-P.. 2018. High prevalence of extended-spectrum β-lactamase-producing enterobacteriaceae in wild fish from the Mediterranean Sea in Algeria. Microb. Drug. Resist. 24:290–298.
31.
Mesbah ZekarF., GranierS.A, TouatiA., and MillemannY.. 2020. Occurrence of third-generation cephalosporins-resistant Klebsiella pneumoniae in fresh fruits and vegetables purchased at markets in Algeria. Microb. Drug Resist. 26:353–359.
32.
YaiciL., HaenniM., MétayerV., et al.2017. Spread of ESBL/AmpC-producing Escherichia coli and Klebsiella pneumoniae in the community through ready-to-eat sandwiches in Algeria. Int. J. Food. Microbiol. 245:66–72.
33.
ChenoufN.S., CarvalhoI., MessaïC.R, et al.2021. Extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae from broiler liver in the Center of Algeria, with detection of CTX-M-55 and B2/ST131-CTX-M-15 in Escherichia coli. Microb. Drug. Resist. 27:268–276.
34.
TouatiA., BenallaouaS., DjoudiF., MadouxJ., BrasmeL., and De ChampsC.. 2007. Characterization of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from hospital environments in Algeria. Microb. Drug Resist. 13:85–89.
35.
ZenatiK., SahliF., GarciaV., et al.2017. Occurrence and clonal diversity of multidrug-resistant Klebsiella pneumoniae recovered from inanimate surfaces in Algerian hospital environment: first report of armA, qnrB and aac(6’)-Ib-cr genes. J. Glob. Antimicrob. Resist. 10:148–153.
36.
AlouacheS., EstepaV., MessaiY., RuizE., TorresC., and BakourR.. 2014. Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria. Microb. Drug Resist. 20:30–38.
37.
AnssourL., MessaiY., DerkaouiM., et al.2014. ESBL, plasmidic AmpC, and associated quinolone resistance determinants in coliforms isolated from hospital effluent: first report of qnrB2, qnrB9, qnrB19, and blaCMY-4 in Algeria. J. Chemother. 26:74–79.
38.
World Health Organization. 2005. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. Livre de Poche Pour Soins Hospitaliers Pédiatriques: Prise En Charge Des Affections Courantes Dans Les Petits Hôpitaux. World Health Organization,, Geneva, Switzerland.
39.
VardakasK.Z., TansarliG.S, RafailidisP.I, and FalagasM.E.. 2012. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J. Antimicrob. Chemother. 67:2793–2803.
40.
TammaP.D., HanJ.H, RockC., et al., and Antibacterial Resistance Leadership Group. 2015. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clin. Infect. Dis. 60:1319–1325.
41.
LiuY.M., LiB.B, ZhangY.Y, et al.2014. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in Mainland China. Antimicrob. Agents Chemother. 58:5379–5385.
42.
ShenP., BerglundB., ChenY., et al.2020. Hypervirulence markers among non-ST11 strains of carbapenem- and multidrug-resistant Klebsiella pneumoniae isolated from patients with bloodstream infections. Front. Microbiol. 11:1199.
43.
YanJ.-J., ZhengP.-X, WangM.-C, TsaiS.-H, WangL.-R, and WuJ.-J. 2015. Allocation of Klebsiella pneumoniae bloodstream isolates into four distinct groups by ompK36 typing in a Taiwanese University Hospital. J. Clin. Microbiol. 53:3256–3263.
44.
MairiA., PantelA., OusalemF., SottoA., TouatiA., and LavigneJ.-P.. 2019. OXA-48-producing Enterobacterales in different ecological niches in Algeria: clonal expansion, plasmid characteristics and virulence traits. J. Antimicrob. Chemother. 74:1848–1855.
45.
MelloukF.Z., BakourS., MeradjiS., et al.2017. First detection of VIM-4-producing Pseudomonas aeruginosa and OXA-48-producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria. Microb. Drug Resist. 23:335–344.
46.
KhaertynovK.S., AnokhinV.A, RizvanovA.A, et al.2018. Virulence factors and antibiotic resistance of Klebsiella pneumoniae strains isolated from neonates with sepsis. Front. Med. (Lausanne), 5:225.
47.
LawlorM.S., O'ConnorC., and MillerV.L.. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect. Immun. 75:1463–1472.
48.
LamM.M.C., WickR.R, WyresK.L, et al.2018. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb. Genom. 4:e000196.
49.
FaïsT., DelmasJ., BarnichN., BonnetR., and DalmassoG.. 2018. Colibactin: More than a new bacterial toxin. Toxins (Basel). 10:151.
50.
MurphyC.N., MortensenM.S, KrogfeltK.A, and CleggS.. 2013. Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect. Immun. 81:3009–3017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
